- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Special Issues
Materials publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Mechanisms of Antimicrobial Treatment in Human Diseases
Deadline: 20 June 2026
Progress of Nanoparticles in the Treatment of Cancers
Deadline: 20 June 2026
Novel Insights into Developing Therapeutic Strategies for Neurological Disorders
Deadline: 15 June 2026
Regulation of Hormone Secretion from Islets in Health and Disease
Deadline: 15 June 2026
Novel Insights into Molecular Mechanisms and Therapy of Myeloma
Deadline: 10 June 2026
Molecular Mechanisms of Fibrosis in Chronic Liver Diseases
Deadline: 1 June 2026
Human Pluripotent Stem Cells and Organoids: Current Trends and Future Perspectives
Deadline: 1 June 2026
Proteomic Applications in Ageing and Neurodegenerative Conditions
Deadline: 31 May 2026
Intervertebral Disc Degeneration and Regeneration: New Molecular Mechanisms and Therapeutics—Second Edition
Deadline: 31 May 2026
The Multifaceted Role of Molecular Chaperones in Cancer: Pro-Tumoral or Therapeutic Function
Deadline: 31 May 2026
Cellular and Molecular Basis of Brain Tumor
Deadline: 31 May 2026
Development and Characterization of Innovative In Vitro Models
Deadline: 31 May 2026
of 137